Citadel Advisors
AWH

Citadel Advisors’s Aspira Women's Health Inc. Common Stock AWH Stock Holding History

Citadel Advisors’s Portfolio AWH Stock Details AWH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-7
Closed -$33 – 15774
2022
Q4 		$33 Buy
+7
New +$38 ﹤0.01% 14796
2021
Q3 		– Sell
-1,067
Closed -$90K – 14884
2021
Q2 		$90K Sell
1,067
-1,613
-60% -$139K ﹤0.01% 13002
2021
Q1 		$271K Buy
2,680
+1,693
+172% +$186K ﹤0.01% 11076
2020
Q4 		$99K Buy
+987
New +$65.9K ﹤0.01% 10230
2020
Q3 		– Sell
-1,033
Closed -$60K – 10920
2020
Q2 		$60K Buy
+1,033
New +$69K ﹤0.01% 9227

Other funds holding AWH

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
QPW
Quantum Private Wealth Tampa, Florida $390M AUM 58.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PVI
Pine Valley Investments Marlton, New Jersey $2.53B AUM 36.18% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Citadel Advisors's AWH Position: Q3 2024 in Review

Citadel Advisors sold out of Aspira Women's Health Inc. Common Stock (AWH) in Q3 2024, closing a stake of 11,754 shares — an estimated $17.5K sold.

Citadel Advisors first reported a position in AWH in Q3 2020 and held it in 9 quarters. The position peaked at $353K in Q4 2021. 25 funds tracked by Wall St. Rank hold AWH as of Q3 2024.

  • Citadel Advisors reported no remaining Aspira Women's Health Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Citadel Advisors sold 11,754 Aspira Women's Health Inc. Common Stock shares in Q3 2024, an estimated $17.5K.
  • Citadel Advisors first reported a position in Aspira Women's Health Inc. Common Stock in Q3 2020 and held it in 9 quarters.
  • Citadel Advisors's Aspira Women's Health Inc. Common Stock position peaked at $353K in Q4 2021.
  • 25 funds tracked by Wall St. Rank held Aspira Women's Health Inc. Common Stock as of Q3 2024.

Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.